Long name
Recombinant Dog Neuropeptide Y receptor type 1 (NPY1R)
Alternative names
neuropeptide Y receptor type 1; Neuropeptide Y receptor type 1; neuropeptide Y receptor type 1; NPY1-R;
Gene name
N/A
Other gene names
NPY1R; NPY1R; NPY1-R
General description
Neuropeptide Y receptor type 1 (NPY1R) is a recombinant protein expressed in E. coli. The protein can be with or without a His-Tag or other tag in accordance to customer's request. All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility.
Product category
Recombinant Proteins
Expression system
E. coli
Available also expressed in:
E Coli ; Yeast
Purity
Greater than 90% (determined by SDS-PAGE)
Form
This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage
This protein can be stored at -20 degrees Celsius. For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius. Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains.
Applications
This protein can be used as a positive control for applications such as ELISA, IFA, RIA, Western Blot, etc.
Properties
Canine or Canis Lupus is mostly Beagle used for drug research. MBS Recombinant produces ELISA test kits and polyclonal antibodies.
Description
The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.